- Business
- Cigniti Technologies Limited Cigniti Technologies Ltd (CIGNITITEC:NSI), a Coforge company, provides AI and IP-led digital assurance and digital engineering services to global enterprises across industries including banking, financial services, retail, e-commerce, healthcare, life sciences, airlines, communications, energy, utilities, insurance, logistics, media, and entertainment; its core offerings encompass digital assurance services such as artificial intelligence testing, big data and analytics testing, blockchain testing, cloud migration assurance, security assurance, IoT testing, mobile testing, robotic process automation, and 5G assurance; quality engineering services including accessibility, DevOps, compatibility, functional, performance, security, regression, test automation, and crowdsourced testing; enterprise application assurance comprising medical device testing, ERP testing, and Salesforce testing; test management services such as agile testing, service virtualization, and test data management; digital engineering services featuring programmatic innovation, Agile and DevOps transformation advisory, DevSecOps, application modernization, blockchain engineering, enterprise application development, user experience engineering, site reliability engineering, data insights, AI and machine learning, cloud migration assurance, and FinOps; as well as intelligent automation through RPA solutions and proprietary IP platforms like BlueSwan and Zastra. The company, founded in 1998 and headquartered in Hyderabad, India, with key offices in Irving, Texas; London, UK; and presence across the US, Canada, Australia, UAE, Czech Republic, South Africa, Singapore, and global delivery centers, employs approximately 4,200 professionals serving over 60 Fortune 500 clients. In recent developments, Coforge Limited acquired a majority stake of up to 54% in 2024 through definitive agreements and an open offer, completed the open offer holding 32.68% by November 2024 with expectations of full acquisition by Q3 FY25, received CCI approval in June 2024 and stock exchange approvals for promoter reclassification in November 2025, and approved a merger scheme in late 2024 anticipated for completion by December 2025-January 2026 via a 1:5 share swap ratio, aiming to create synergies in AI-led assurance, expand into retail, healthcare, hi-tech verticals, scale revenue toward $2 billion by FY27, and strengthen US market presence in South-West, Mid-West, and Western regions.